Literature DB >> 17482716

Reliability of the histopathologic diagnosis of keratinocyte carcinomas.

Jared Jagdeo1, Martin A Weinstock, Michael Piepkorn, Stephen F Bingham.   

Abstract

OBJECTIVE: We sought to determine the interobserver reliability of the histopathologic diagnosis of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) (keratinocyte carcinomas) in the setting of a Department of Veteran Affairs multicenter chemoprevention study.
METHODS: Interobserver concordance was assessed by blinded review of histopathologic slides by study dermatopathologists.
RESULTS: Overall interobserver agreement between the two dermatopathogists was kappa = 0.69 (95% confidence interval [CI] 0.67-0.69). The dermatopathologists' interobserver agreement was highest for basal cell carcinoma at kappa = 0.88 (95% CI 0.84-0.91) and for a diagnostic category in the SCC-actinic keratosis spectrum at kappa = 0.80 (95% CI 0.73-0.86). The largest disagreements between the two reference dermatopathologists were regarding the categories of invasive SCC at kappa = 0.62 (95% CI 0.52-0.72), SCC in situ at kappa = 0.42 (95% CI 0.29-0.56), and actinic keratosis at kappa = 0.51 (95% CI 0.40-0.62). Agreement between the local pathologists and central reference dermatopathologists were similar to the agreement between the central dermatopathologists. The morphea subtype of basal cell carcinoma was the only reliably diagnosed subtype (kappa = 0.79, 95% CI 0.51-1.00), and tumor depth was reliably measured. LIMITATIONS: A limitation of this study was the use of only two reference dermatopathologists.
CONCLUSION: Because of the impact on physician decision making and patient care, researchers and clinicians need to be aware of reliability of histopathology results, particularly pertaining to the SCC and actinic keratosis spectrum.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482716     DOI: 10.1016/j.jaad.2007.03.021

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Wogonoside Attenuates Cutaneous Squamous Cell Carcinoma by Reducing Epithelial-Mesenchymal Transition/Invasion and Cancer Stem-Like Cell Property.

Authors:  Xiuyong Wang; Yuan Chang; Ming Gao; Fan Zhang
Journal:  Onco Targets Ther       Date:  2020-10-09       Impact factor: 4.147

2.  Differential expression of tetraspanin CD9 in basal cell and squamous cell carcinomas of the skin and actinic keratosis.

Authors:  Thomas Ach; Mirjana Ziemer; Jens Dawczynski; Jürgen Strobel; Georg Sauer; Helmut Deissler
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

3.  Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.

Authors:  David D Dore; Kate L Lapane; Amal N Trivedi; Vincent Mor; Martin A Weinstock
Journal:  Ann Intern Med       Date:  2009-01-06       Impact factor: 25.391

4.  Squamous cell carcinoma: variation in dermatoscopic vascular features between well and non-well differentiated tumors.

Authors:  John Pyne; Devendra Sapkota; Jian Cheng Wong
Journal:  Dermatol Pract Concept       Date:  2012-10-31

5.  Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1.

Authors:  Xiu-Ying Lin; Chun-Di He; Ting Xiao; Xin Jin; Jiang Chen; Ya-Kun Wang; Mei Liu; Kai-Bo Wang; Yi Jiang; Hua-Chen Wei; Hong-Duo Chen
Journal:  J Cell Mol Med       Date:  2009-06-20       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.